disease/infection early, rather than wait until it has caused damage.
The limiting factor with HIV has always been the issue of long term
compliance, resistance and drug toxicity. Risk benefit analysis
indicates it is appropriate to delay treatment, but not for too long.
As drugs become simpler to take, improving compliance and reducing the
chance of resistance selection, and less toxic, the balance will
naturally swing back in favour of hitting early.